Robert A Kratzke

Emailkratz003umnedu

Research activity per year

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

1 Similar Profiles

10 Active
27 Finished

Targeting ADAR1 with siRNA using an innovative intra-cavitary nanoparticle hydrogel composite
Kratzke, R. A. (PI) & Jacobson, B. A. (Other Role)
MESOTHELIOMA APPLIED RESEARCH FOUNDATION
7/1/25 → 6/30/27
Project: Research project
A Phase 3 open-label, randomized, active-controlled, multicenter trial to evaluate the efficacy and safety of orally administered BAY 2927088...
Kratzke, R. A. (PI)
BAYER HEALTHCARE PHARMACEUTICALS
10/28/24 → 10/27/35
Project: Research project
A Phase 3b, Multicenter, Single-arm, Expanded Access Protocol of Tarlatamab (AMG 757) for theTreatment of Subjects with Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment
Kratzke, R. A. (PI)
AMGEN INC
3/29/24 → 3/31/34
Project: Research project
A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in SubjectsWith Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy (DeLLphi-304)
Kratzke, R. A. (PI)
AMGEN INC
3/12/24 → 5/31/28
Project: Research project
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K. (PI), Geller, M. A. (CoI), Greeno, E. W. (CoI), Kratzke, R. A. (CoI), Ondrey, F. G. (CoI), Teoh, D. G. (CoI) & Yee, D. (CoI)
NIH NATIONAL CANCER INSTITUTE
9/18/23 → 8/31/28
Project: Research project

147 Article
11 Review article
4 Chapter
2 Editorial
More
- 1 Comment/debate
- 1 Letter

GPR81 nuclear transportation is critical for cancer growth and progression in lung and other solid cancers
Yang, L., Kono, T., Gilbertsen, A., Li, Y., Sun, B., Jacobson, B. A., Karam, S., Dehm, S. M., Henke, C. A. & Kratzke, R. A., Aug 24 2025, In: World Journal of Clinical Oncology. 16, 8, p. 107208
Research output: Contribution to journal › Article › peer-review

Open Access
International guidelines on the diagnosis and treatment of NUT carcinoma
Zhang, Y., Zhang, Q., Hao, Y., Luo, J., Piao, Y., Wang, W., Song, Z., Li, Z., Brcic, L., Liu, A., Yu, J., Tsutani, Y., Zhong, W., Fang, W., Wang, Z., Ren, S., Papavassiliou, A. G., Zhang, Y., Liu, J. & Zhang, S. & 154 others, Cai, X., Cangir, A. K., Liu, A., Li, W., Lococo, F., Zhan, P., Liu, H., Lv, T., Miao, L., Min, L., Popper, H., Chen, Y., Yuan, J., Wang, F., Jiang, Z., Lin, G., Huang, L., Pu, X., Lin, R., Kairemo, K., Liu, W., Rao, C., Lv, D., Yu, Z., Leanne, A., Li, X., Tang, C., Siddique, H. R., Zhou, C., Zhang, J., Xue, J., Shelat, V., Guo, H., Chu, Q., Meng, R., Ardeshir, F., Wu, J., Zhang, R., Zhou, J., Kratzke, R. A., Zhu, Z., Li, Y., Qiu, H., Xia, F., Calabrese, F., Xia, Y., Mariani, A. W., Lu, Y., Chen, X., Klein, M. A., Ge, R., Dai, E., Schönthal, A. H., Han, Y., Guo, Z., Zhang, J., Ji, Y., Liang, X., Zhang, H., Ma, X., Chiappetta, M., Liu, X., Salle, F. G., Yao, Y., Szolkowska, M., Pan, W., Pang, F., Wu, F., Watzka, S. B., Wang, L., Zhu, Y., Lin, L., Sharma, A., Tu, J., Lin, X., Cai, J., Xu, L., Li, J., Jiao, X., Li, K., Zauderer, M. G., Wei, J., Feng, H., Wang, L., Du, Y., Yao, W., Dudnik, E., Shi, X., Niu, X., Yuan, D., Yao, Y., Huang, J., Feng, Y., Zhang, Y., Song, B., Li, W., Fu, J., Baine, M. K., Sun, P., Wang, H., Ye, M., Wang, D., Wang, Z., Wu, J., Yang, Y., Fang, Y., Wang, Z., Wan, B., Lv, D., Chen, H., Yang, S., Kang, J., Zhang, J., Zhang, C., Shi, L., Wang, Y., Sobeih, M. E., Li, B., Lian, B., Mao, L., Zhang, Z., Wang, K., Li, Z., Liu, Z., Yang, N., Wu, L., Chen, X., Jin, G., Li, M., Wang, G., Marron, T. U., Wang, J., Popat, S., Fang, M., Fang, Y., Mansilla, D., Li, Y., Wang, X., Chen, J., Zhang, Y., Zhu, X., Shen, Y., Ma, S., Mansfield, A. S., Wang, B., Si, L., Roden, A. C., Grønberg, B. H., Song, Y., Shapiro, G. I., French, C. A., Lu, Y., Wang, Q. & Xu, C., 2025, (Accepted/In press) In: Innovation. 101068.
Research output: Contribution to journal › Review article › peer-review

Open Access
SFPQ subcellular mislocalisation entails altered cancer cell function
Yang, L., Gilbertsen, A., Jacobson, B., Kratzke, R., Li, Y., Sun, B., Karam, S., Dehm, S. M. & Henke, C. A., Aug 6 2025, In: Clinical and Translational Medicine. 15, 8, p. e70431
Research output: Contribution to journal › Article › peer-review

Open Access
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
Yap, T. A., Kwiatkowski, D. J., Dagogo-Jack, I., Offin, M., Zauderer, M. G., Kratzke, R., Desai, J., Body, A., Millward, M., Tolcher, A. W., Raghav, K. P. S., Thurston, A., Post, L., Dorr, F. A., Tang, T. T., Li, Y., Sharma, N. & Kindler, H. L., 2025, (Accepted/In press) In: Nature Medicine.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation
Belhadj, Z., Offei, S., Jacobson, B. A., Cambron, D., Kratzke, R. A., Wang, Z. & Xie, J., Feb 1 2024, In: European Journal of Pharmaceutical Sciences. 193, 106686.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

Robert A Kratzke

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Targeting ADAR1 with siRNA using an innovative intra-cavitary nanoparticle hydrogel composite

A Phase 3 open-label, randomized, active-controlled, multicenter trial to evaluate the efficacy and safety of orally administered BAY 2927088...

A Phase 3b, Multicenter, Single-arm, Expanded Access Protocol of Tarlatamab (AMG 757) for theTreatment of Subjects with Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in SubjectsWith Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy (DeLLphi-304)

Increasing access to cancer trials in Minnesota (InACT-MN)

GPR81 nuclear transportation is critical for cancer growth and progression in lung and other solid cancers

International guidelines on the diagnosis and treatment of NUT carcinoma

SFPQ subcellular mislocalisation entails altered cancer cell function

YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation

Robert A Kratzke

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output